%0 Journal Article
%A Gil, M. M.
%A Rodriguez-Fernandez, M.
%A Elger, T.
%A Akolekar, R.
%A Syngelaki, A.
%A De Paco Matallana, C.
%A Molina, F. S.
%A Gallardo Arocena, M.
%A Chaveeva, P.
%A Persico, N.
%A Accurti, V
%A Kagan, K. O.
%A Prodan, N.
%A Cruz, J.
%A Nicolaides, K. H.
%T Risk of fetal loss after chorionic villus sampling in twin pregnancy derived from propensity score matching analysis
%D 2022
%@ 0960-7692
%U https://hdl.handle.net/10668/26017
%X Objective To estimate the risk of fetal loss associated with chorionic villus sampling (CVS) in twin pregnancy, using propensity score analysis. Methods This was a multicenter cohort study of women with twin pregnancy undergoing ultrasound examination at 11-13 weeks' gestation, performed in eight fetal medicine units in which the leadership were trained at the Harris Birthright Research Centre for Fetal Medicine in London, UK, and in which the protocols for screening, invasive testing and pregnancy management are similar. The risk of death of at least one fetus was compared between pregnancies that had and those that did not have CVS, after propensity score matching (1:1 ratio). This procedure created two comparable groups by balancing the maternal and pregnancy characteristics that lead to CVS being performed, similar to how randomization operates in a randomized clinical trial. Results The study population of 8581 twin pregnancies included 445 that had CVS. Death of one or two fetuses at any stage during pregnancy occurred in 11.5% (51/445) of pregnancies in the CVS group and in 6.3% (515/8136) in the non-CVS group (P
%K adverse pregnancy outcome
%K chorionic villus sampling
%K CVS
%K first-trimester screening
%K invasive procedure
%K invasive testing
%K miscarriage
%K pregnancy complications
%K prenatal diagnosis
%K Nuchal translucency
%K Prediction
%K Model
%~